Inflamatory reaction in acute myocardial infarction. Predictive values;Respuesta inflamatoria en el infarto agudo de miocardio. Valores predictivos

Revista Espanola de Cardiologia

Volumn 50, Issue 8, 1997, Pages 561-566

  Sanjuán Máñez, Rafael ^a,b   Blasco Cortés, Marisa ^a   Muñoz Gil, Jaime ^a   Gimeno Cardona, Concepción ^a   Savall Calvo, Francisca ^a   Ferreres Franco, José ^a   Bodí Peris, Vicente ^a   Samper Codes, Josefa ^a   Morell Cabedo, Salvador ^a   López Merino, Vicente ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

AGED; ARTICLE; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MYOCARDITIS; PREDICTION AND FORECASTING; PROGNOSIS; RISK; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; DATA INTERPRETATION, STATISTICAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDITIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; THROMBOLYTIC THERAPY;

EID: 0031205448     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(97)73264-0     Document Type: Article

References (24)

1. Abbas AK, Lichtman AH, Pober JS, editores. Inmunología celular y molecular, Madrid: Interamericana-McGraw-Hill, 1995.
2. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995; 91: 1.872-1.885.
3. Alexander RW. Inflamation and coronary diseases. N Engl J Med 1994; 331: 468-469.
4. Laskin DL, Pendino KL. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 1995; 35: 655-677.
5. Tashiro H, Shimokawa H, Yamamoto K, Nagano M, Momohara M, Murumatu K et al. Monocyte-related cytokines in acute myocardial infarction. Am Heart J 1995; 130: 446-452.
6. Bell D, Jackson M, Nicoll JJ, Millar A, Dawes J, Muir AL. Inflamatory response, neutrophil activation, and free radical production after acute myocardial infarction: effect of thrombolytic treatment. Br Heart J 1990; 63: 82-87.
7. Airaghi L, Lettino M, Grazia Manfredi M, Matthew J, Catania A. Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy. Am Heart J 1995; 130: 204-211.
8. Blum A, Sclarovsky S, Rehavia E, Shohat B. Levels of T-lymphocyte subpopulations, mterleukin-1B, and soluble interleukin-2 receptor in acute myocardial infarction. Am Heart J 1994; 127: 1.226-1.230.
9. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys M et al. The pronostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331: 417-424.
10. Ueda S, Ikeda U, Yamamoto K, Takahashi M, Nishinaga M, Nago N et al. C-reactive protein as predictor of cardiac rupture after acute myocardial infarction. Am Heart J 1996; 131: 857-860.
11. Burgueño MJ, García Bastos JL, González-Buitrago JM. Las Curvas ROC en la evaluación de las pruebas diagnósticas Med Clin (Barc) 1995; 104: 661-670.
12. Barrabés JA, Gonzalez MA, Ruiz Meana M, García Dorado D. Control farmacológico de la respuesta inflamatoria durante la reperfusion miocárdica. En: Fernández Avilés F, Iñíguez Romo A, Alonso Martín J, Pérez Villacastin J, editores. Farmacologia Cardiovascular. Madrid: SEC, 1996; 162-168.
13. De Beer FC, Hind CPK, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum CRP concentration in myocardial infarction and ischemia. Br Heart J 1982; 47: 239-243.
14. Pietilä K, Harmoinem AP, Tepo A. Acute phase reaction infarct size and in-hospital morbidity in myocardial infarction patients treated with streptokinase or recombinant tissue plasminogen activator. Ann Med 1992; 23: 529-535.
15. Pietilä K, Harmoinen A, Hermens W, Simoons ML, Van de Werf F, Verstraete M. Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarctrelated coronary artery after thrombolytic therapy. Eur Heart J 1993; 14: 915-919.
16. Maseri A, Biasucci LM, Liuzzo G. Determinants of the acute phase response in acute myocardial infarction. Eur Heart J 1996; 17: 1.301-1.302.
17. Guillén I, Blanes M, Gómez-Lechón MJ, Castell JV. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. Am J Physiol 1995; 269: R229-R235.
18. Granger DN, Korthuis RJ. Physiologic mechanisms of post-ischemic tisue injury. Annu Rev Physiol 1995; 57: 311-332.
19. Ricevuti G, De Servi S, Mazzone A, Angoli L, Ghio S, Specchia G. Increased neutrophil aggregability in coronary artery disease. Eur Heart J 1990; 11: 814-818.
20. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic heart disease. J Am Med Assoc 1987; 257: 2.318-2.324.
21. Kostis JB, Turkevich D, Sharp J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. Am J Cardiol 1984; 53: 997-999.
22. Syrjala H, Surcel HM, Ilonen J. Low CD4/CD8 lymphocyte ratio in acute myocardial infarction. Clin Exp Immunol 1991; 83: 326-328.
23. Pietilä KO, Harmoinen AP, Jokiniitty J, Pasternack AI. Serum C reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J 1996; 17: 1.345-1.349.
24. Cabadés A, Valls F, Echanove I, Francés M, Sanjuán R, Calabuig J et al. Registro de pacientes con infarto agudo de miocardio de la ciudad de Valencia. Estudio multicéntrico hospitalario RICVAL. Rev Esp Cardiol 1997; 50: 383-396.